Paragon 28, Inc. (FNA)
- Previous Close
9.80 - Open
9.88 - Bid --
- Ask --
- Day's Range
9.56 - 9.88 - 52 Week Range
7.95 - 19.72 - Volume
272,947 - Avg. Volume
523,495 - Market Cap (intraday)
811.651M - Beta (5Y Monthly) 1.01
- PE Ratio (TTM)
-- - EPS (TTM)
-0.58 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
18.00
Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.
paragon28.comRecent News: FNA
Performance Overview: FNA
Trailing total returns as of 4/22/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FNA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FNA
Valuation Measures
Market Cap
811.65M
Enterprise Value
846.45M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.71
Price/Book (mrq)
4.57
Enterprise Value/Revenue
3.91
Enterprise Value/EBITDA
-31.44
Financial Highlights
Profitability and Income Statement
Profit Margin
-22.11%
Return on Assets (ttm)
-7.84%
Return on Equity (ttm)
-30.03%
Revenue (ttm)
216.39M
Net Income Avi to Common (ttm)
-47.84M
Diluted EPS (ttm)
-0.58
Balance Sheet and Cash Flow
Total Cash (mrq)
75.64M
Total Debt/Equity (mrq)
63.03%
Levered Free Cash Flow (ttm)
-79.88M